05 November 2018 – Game Studio Epic Games Raises $1.25bn

Deals

Game studio Epic Games has had some very notable successes including the Unreal and Gears of War series, but it’s entered the mainstream in a huge way over the past year with Fortnite, a game that passed the $1bn revenue mark in 10 months. It’s also raised $1.25bn in a round that included a strategic investment by eSports team owner Axiomatic, valuing it at almost $15bn.

Zume began as a pizza delivery service that utilised robotics technology to help prepare the food, and now it’s looking to expand that model into other parts of the food industry. To that end, SoftBank Vision Fund has reportedly paid $375m for a 20% stake in the company and is set to invest a further $375m in a deal that will value Zume at $2.25bn post-money.

Coinbase has secured $300m in a Tiger Global Management-led series E round that valued it at $8bn post-money. The company, which has built a trading platform and digital wallet for cryptocurrencies, has now raised a total of almost $520m in funding since 2012, and its existing investors include New York Stock Exchange, Docomo Capital, BBVA, Mitsubishi UFJ Financial Group and USAA, none of which took part in the latest round.

China has played host to several smart electric vehicle producers and one of them, WM Motor, is reportedly in talks to raise some $287m in funding, with half of the cash to be put up by Baidu, sources have told Reuters (though WM itself suggested the figure would be 50% higher).

Grab, the Southeast Asian ride hailing platform that has moved into mobile services and payment technology, has received $200m from Booking Holdings, the travel and accommodation booking service formerly known as Priceline, as part of a strategic alliance.

Chinese music tutoring service Peilian has raised $150m from investors including Tencent, in a series C round that came less than a year after its series B.

Southeast Asian real estate platform PropertyGuru has raised $145m in a series D round led by KKR that boosted its overall funding to about $325m.

India-based online grocer Grofers is reportedly in talks with existing investor SoftBank over a round sized between $100m and $150m that could value it at up to $650m.

The lidar sensor industry is one that has been attracting ever increasing amounts of funding, and one of its companies, Quanergy, has just raised an undisclosed sum in a round that valued it at more than $2bn.

Galecto Biotech, a Denmark-based developer of treatments for cancer and fibrosis based on research at Lund and Edinburgh universities, closed a $90m series C round co-led by Ysios Capital and OrbiMed.

And Astroscale, a Singapore-based space debris removal technology developer, raised $50m on Wednesday in a series D round featuring property developer Mitsubishi Estate and games publisher Koei Tecmo’s Koei Tecmo Capital investment unit.

Funds

Five Japan-based financial services groups have agreed to form a fund in partnership with sovereign wealth fund China Investment Corporation (CIC) reported by Bloomberg to be up to $1.8bn in size.

Arch Venture Partners, the venture capital firm spun out of University of Chicago, is aiming to raise $600m for its tenth fund. The firm has not yet raised any money but if it reaches its $600m target, Fund X would be the largest flagship vehicle raised by Arch to date and bring total assets under management to $2.86bn.

Exits

StoneCo has made a big step forward for Brazilian startups, securing more than $1.22bn in an IPO that came alongside a $100m private placement by Ant Financial.

Orchard Therapeutics has raised $200m in an IPO that involved it floating at the foot of its range but upping the number of shares involved.

Medical device developer Axonics Modulation Technologies has floated in a $120m initial public offering in which it increased the number of shares and floated in the middle of its range.

Twist Bioscience has gone public in a $70m IPO that saw it float at the bottom of its range.

Video conferencing software provider Zoom is looking to float in an initial public offering in which it will seek a valuation significantly above the $1bn valuation at which it last raised cash almost two years ago.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

15 October 2018 – Saudi Arabia’s Public Investment Fund Invests $45bn in SoftBank’s Second Vision Fund

Funds

SoftBank has for a few months discussed its intentions to launch a second $100bn Vision Fund, and it will have received a hefty incentive with news that Saudi Arabia’s Public Investment Fund intends to put up $45bn for the new fund.

Foxconn has formed a $545m investment fund that will invest in semiconductor ventures including the launch of five integrated-circuit design companies and one high-performance chip developer.

Tencent Investments, internet group Tencent’s corporate venturing unit, is meanwhile in talks with family offices and other potential limited partners for a $650m fund that will focus on follow-on investments in its portfolio companies.

Chrysalix takes corporates to RoboValley for new fund

Another interesting development in the past two or three years has been the increased entry of packaged food producers into corporate venturing. The likes of Kellogg, General Mills and Tyson Foods have been joined by Kraft Heinz, which is committing $100m to an investment initiative called Evolv Ventures.

University

Theodorus unveils $23m fund

Université libre de Bruxelles has added a fourth Theodorus fund to its arsenal with an initial close of $23m and a target of up to $33.5m.

Yissum fabricates $6m nanotech fund

HUJ’s tech transfer arm still hopes to raise a further $3m for the fund for a $9m close, and it has already invested in three technologies.

Deals

SoftBank has pumped billions of dollars into workspace provider WeWork to build up a stake of almost 20%, and the WSJ has reported that its Vision Fund is now considering an investment between $15bn and $20bn that will give it a majority stake in the company.

Xiaozhu, the short-term accommodation platform seen by many as China’s Airbnb, hasraised almost $300m in a round led by Yunfeng Capital.

Snowflake Computing has to be one of the fastest growing companies in the startup space right now. The data warehousing software provider raised $263m at a post-money valuation of $1.76bn in January and now, nine months later, has secured $450m in a round that valued it at $3.95bn post-money.

There’s been a lot about digital banking in recent months but much of the dealflow has been going on in Europe. Nubank however is showing that the model can be expanded to other markets, and the Brazilian company has raised $180m from Tencent at a reported $4bn valuation.

JFrog jumps to $165m series D

University

Glympse Bio engineers $22m series A

Exits

Redlock heads to Palo Alto in $173m acquisition

GV exits as Anju inhales Zephyr

Orchard Therapeutics has filed to raise almost $173m in an initial public offering, having secured more than $290m in equity funding in under three years. GlaxoSmithKline is the gene therapy developer’s second largest shareholder, with a 17.9% stake, while Medison and Sphera Global Health Care are also investors, having participated in its $150m series C round in August.

Synthetic DNA producer Twist Bioscience has filed to raise up to $86.3m in an initial public offering on the Nasdaq Global Market.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

20 August 2018 – Podcast and Radio Streaming Service Ximalaya Secures $580m

Deals

With much of the western VC industry seemingly on summer holiday (and frankly, who can blame them?), it’s up to China to pick up the slack in corporate venturing. Ximalaya, the operator of a streaming platform for radio shows and podcasts, has secured $580m in a Tencent-backed round that reportedly valued it at about $3.5bn post-money.

Pfizer has provided an undisclosed amount of equity funding for immunotherapy developer Biontech as part of a collaboration agreement that could reach $425m if it reaches every milestone.

Alphabet has paid about $375m for a stake of around 10% in health insurance provider Oscar Health, which will put the funding toward beefing up its existing team.

TZero, a blockchain lending technology developer spun off from listed e-commerce firm Overstock, is raising up to $270m from GSR Capital, which is set to acquire an 18% stake in the company.

DoorDash, a last-mile delivery service for restaurants, appears to be one of the success stories of 2018. The company was valued at $1.4bn post-money when it raised $535m in a SoftBank-led round in March, but has now raised another $250m at a whopping $4bn valuation just five months later.

Orchard Therapeutics, which is working on gene therapies for rare diseases based on research at University College London, has secured $150m in a series C round that included Sphera Global and corporate venturing unit Medison Ventures.

Exabeam, a cybersecurity information and event management software provider, has raised $50m in series D cash from backers including Cisco Investments.

Funds

E-commerce firm JD.com has begun taking a more active part in corporate venturing in the past year or two, backing the likes of Traveloka, Dada-JD Daojia, Aihuishou and Go-Jek at growth stage alongside post-IPO investments in companies such as Secoo and VIPshop.

Educational services firm New Oriental Education and Technology has put together a $220m fund that will invest between $3m and $15m in early-stage education-focused startups in China.

Exits

Electric vehicle developer Nio recently began shipping its first commercial vehicle, and now it’s filed for a $1.8bn initial public offering in the US.

Babytree, the social parenting community that has branched out into e-commerce, is looking to raise between $800m and $1bn in its Hong Kong IPO, sources have told Reuters, adding that it is seeking a valuation between $3bn and $5bn in the offering.

Weidai, which runs a lending service that uses borrowers’ vehicles as collateral, has filed for a $100m IPO in the US that could give exits to corporate investors Hakim Unique, Shanda and Dong Yi Ri Sheng Home Decoration.

On GUV, Sensyne Health, a UK-based healthcare technology developer partially based on research at University of Oxford, raised £60m ($76m) in its initial public offering on Tuesday and began trading on Aim on Friday.

And Quethera, a UK-based glaucoma therapy developer spun out from University of Cambridge, has been acquired by pharmaceutical firm Astellas Pharma for up to $108m in cash and contingent commitments.

And a nice exit for corporate, university and government venturing entities was Millendo Therapeutics, a US-based endocrine disease drug spinout of University of Michigan, which agreed to a reverse merger with US-listed fertility treatment provider OvaScience.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0